Postprandial Hypoglycemia

Metabolic·MeSH: Hypoglycemia

3 drugs in development·2 companies·0 clinical trials

Drug Pipeline by Phase

Phase 2(3)

Drug	Company
anakinra	ENANTA PHARMACEUTICALS INC (ENTA)
anakinra	Cidara Therapeutics, Inc. (CDTX)
empagliflozin	Cidara Therapeutics, Inc. (CDTX)

Full trial data, competitive analysis, and AI-powered pipeline tracking.